| Ident. | Authors (with country if any) | Title |
|---|
| 000031 (2020) |
J. Reina [Espagne] | [Remdesivir, the antiviral hope against SARS-CoV-2]. |
| 000034 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
| 000060 (2020) |
Sergio Rosales-Mendoza [Mexique] | Will plant-made biopharmaceuticals play a role in the fight against COVID-19? |
| 000070 (2020) |
Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique] | What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? |
| 000075 (2020) |
Tuan M. Nguyen [États-Unis] ; Yang Zhang [États-Unis] ; Pier Paolo Pandolfi [États-Unis] | Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. |
| 000077 (2020) |
Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite] | Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. |
| 000091 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000100 (2020) |
Chang-Quan Ling | Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) |
| 000103 (2020) |
Shan Lu | Timely development of vaccines against SARS-CoV-2 |
| 000132 (2020) |
Chu-Xia Deng | The global battle against SARS-CoV-2 and COVID-19 |
| 000185 (2020) |
Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde] | Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. |
| 000187 (2020) |
Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg Doherty | Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment |
| 000196 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000205 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000297 (2020) |
Abdo A. Elfiky | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
| 000330 (2020) |
Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis] | Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status |
| 000362 (2020) |
Jinyong Zhang [République populaire de Chine] ; Hao Zeng [République populaire de Chine] ; Jiang Gu [République populaire de Chine] ; Haibo Li [République populaire de Chine] ; Lixin Zheng [États-Unis] ; Quanming Zou [République populaire de Chine] | Progress and Prospects on Vaccine Development against SARS-CoV-2. |
| 000387 (2020) |
Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran] | Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. |
| 000393 (2020) |
Wen-Hsiang Chen [États-Unis] ; Peter J. Hotez [États-Unis] ; Maria Elena Bottazzi [États-Unis] | Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. |
| 000417 (2020) |
Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine] | Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 |
| 000441 (2020) |
Henry Ji [États-Unis] ; Ying Yan [États-Unis] ; Beibei Ding [États-Unis] ; Wenzhong Guo [États-Unis] ; Mark Brunswick [États-Unis] ; Andreas Niethammer [États-Unis] ; Williams Soohoo [États-Unis] ; Robin Smith [États-Unis] ; Alexis Nahama [États-Unis] ; Yanliang Zhang [États-Unis] | Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus. |
| 000450 (2020) |
Subramanian Boopathi [Chili] ; Adolfo B. Poma [Pologne] ; Ponmalai Kolandaivel [Inde] | Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. |
| 000454 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| 000501 (2020) |
Juan Yu [République populaire de Chine] ; Ning Ding [République populaire de Chine] ; Huan Chen [République populaire de Chine] ; Xia-Jing Liu [République populaire de Chine] ; Zu-Hui Pu [République populaire de Chine] ; Hua-Jian Xu [République populaire de Chine] ; Yi Lei [République populaire de Chine] ; Han-Wen Zhang [République populaire de Chine] | Loopholes in Current Infection Control and Prevention Practices Against COVID-19 in Radiology Department and Improvement Suggestions. |
| 000506 (2020) |
Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine] | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). |
| 000531 (2020) |
L. Cegolon [Italie] | Investigating hypothiocyanite against SARS-CoV-2 |
| 000549 (2020) |
Juan Yu [République populaire de Chine] ; Ning Ding [République populaire de Chine] ; Huan Chen [République populaire de Chine] ; Xia-Jing Liu [République populaire de Chine] ; Wen-Jie He [République populaire de Chine] ; Wei-Cai Dai [République populaire de Chine] ; Zhao-Guang Zhou [République populaire de Chine] ; Fan Lin [République populaire de Chine] ; Zu-Hui Pu [République populaire de Chine] ; Ding-Fu Li [République populaire de Chine] ; Hua-Jian Xu [République populaire de Chine] ; Yu-Li Wang [République populaire de Chine] ; Han-Wen Zhang [République populaire de Chine] ; Yi Lei [République populaire de Chine] | Infection Control against COVID-19 in Departments of Radiology |
| 000558 (2020) |
Phulen Sarma [Inde] ; Nishant Sekhar [Inde] ; Manisha Prajapat [Inde] ; Pramod Avti [Inde] ; Hardeep Kaur [Inde] ; Subodh Kumar [Inde] ; Sanjay Singh [Inde] ; Harish Kumar [Inde] ; Ajay Prakash [Inde] ; Deba Prasad Dhibar [Inde] ; Bikash Medhi [Inde] | In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). |
| 000560 (2020) |
Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie] | In Silico Discovery of Candidate Drugs against Covid-19. |
| 000602 (2020) |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 000607 (2020) |
Maged N. Kamel Boulos ; Estella M. Geraghty [États-Unis] | Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics |
| 000639 (2020) |
Xu Qian [République populaire de Chine] ; Ran Ren [République populaire de Chine] ; Youfa Wang [République populaire de Chine] ; Yan Guo [République populaire de Chine] ; Jing Fang [République populaire de Chine] ; Zhong-Dao Wu [République populaire de Chine] ; Pei-Long Liu [République populaire de Chine] ; Tie-Ru Han [République populaire de Chine] | Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind |
| 000712 (2020) |
Ki Tae Kwon [Corée du Sud] ; Jae Hoon Ko [Corée du Sud] ; Heejun Shin [Corée du Sud] ; Minki Sung [Corée du Sud] ; Jin Yong Kim [Corée du Sud] | Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak. |
| 000795 (2020) |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
| 000799 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
| 000984 (2020) |
Lisi Deng [République populaire de Chine] ; Chunna Li [République populaire de Chine] ; Qi Zeng [République populaire de Chine] ; Xi Liu [République populaire de Chine] ; Xinghua Li [République populaire de Chine] ; Haitang Zhang [République populaire de Chine] ; Zhongsi Hong [République populaire de Chine] ; Jinyu Xia [République populaire de Chine] | Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study |
| 000991 (2020) |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| 000A15 (2020) |
Junyang Li [République populaire de Chine] ; Meicen Liu [République populaire de Chine] ; Jin Gao [République populaire de Chine] ; Yu Jiang [République populaire de Chine] ; Limin Wu [République populaire de Chine] ; Yuen-Ki Cheong [Royaume-Uni] ; Guogang Ren [Royaume-Uni] ; Zhuo Yang [République populaire de Chine] | AVNP2 protects against cognitive impairments induced by C6 glioma by suppressing tumour associated inflammation in rats. |
| 000A40 (2020) |
A-Yong Yu ; Ruixue Tu ; Xu Shao ; Anpeng Pan ; Kaijing Zhou ; Jinhai Huang | A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology |
| 000A95 (2005) |
| MRSA clones hamper battle against infection |
| 000B06 (????) |
Hadis Fathizadeh ; Parham Maroufi [Iran] ; Mansooreh Momen-Heravi [Iran] ; Sounkalo Dao [Mali] ; Kran Köse [Turquie] ; Khudaverdi Ganbarov ; Pasquale Pagliano [Italie] ; Silvano Esposito [Italie] ; Hossein Samadi Kafil [Iran] | Protection and disinfection policies against SARS-CoV-2 (COVID-19). |
| 000B08 (????) |
Idris Nasir Abdullahi [Nigeria] ; Anthony Uchenna Emeribe [Nigeria] ; Jelili Olaide Mustapha [Canada] ; Samuel Ayobami Fasogbon [Nigeria] ; Igr Bassey Ofor [Nigeria] ; Imodoye Sikiru Opeyemi [Nigeria] ; Chibueze Obi-George [Nigeria] ; Animasaun Olawale Sunday [Nigeria] ; Justin Nwofe [Royaume-Uni] | Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19 |
